Atlas Trials

U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer

Clinical trial NCT03260491 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03260491
Sponsor
Daiichi Sankyo
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer (NSCLC)
Start date
2017-10-30
Primary completion
2026-03-31
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.